<![CDATA[The Globe and Mail]]>https://www.theglobeandmail.comTue, 21 Apr 2026 15:43:25 +0000en-caCopyright 2024 The Globe and Mail Inc. All rights reserved.1hourly1https://www.theglobeandmail.com/legacy/static/mobile.flag.rss.pngThe Globe and Mailhttps://www.theglobeandmail.com<![CDATA[Public health plans should cover Mounjaro for Type 2 diabetes, Canada’s Drug Agency recommends]]>https://www.theglobeandmail.com/business/economy/article-canada-drug-agency-mounjaro-recommendation-type-2-diabetes/https://www.theglobeandmail.com/business/economy/article-canada-drug-agency-mounjaro-recommendation-type-2-diabetes/Thu, 16 Apr 2026 11:00:00 +0000]]>George Frey<![CDATA[Apotex wins tentative FDA approval for generic Ozempic, drug makers await Health Canada decisions]]>https://www.theglobeandmail.com/business/economy/article-apotex-fda-approval-generic-ozempic-drug-health-canada-decisions/https://www.theglobeandmail.com/business/economy/article-apotex-fda-approval-generic-ozempic-drug-health-canada-decisions/Sun, 12 Apr 2026 20:37:53 +0000Apotex Inc. has won tentative approval from the U.S. Food and Drug Administration for a cheaper, generic form of Ozempic six years before the patent expires there, while no generic versions have been approved in Canada since they became legal three months ago.

]]>Nathan Denette<![CDATA[Government probes into deaths of two plasma donors find no link to Grifols’ donation process]]>https://www.theglobeandmail.com/canada/article-government-probes-into-deaths-of-two-plasma-donors-find-no-link-to/https://www.theglobeandmail.com/canada/article-government-probes-into-deaths-of-two-plasma-donors-find-no-link-to/Fri, 10 Apr 2026 02:44:28 +0000]]>Shannon VanRaes